Naegleria fowleri-associated primary amoebic meningoencephalitis in India: A systematic review and individual patient data meta-analysis.

Authors

Shreya Singh, Shivani Rathor, Sumeeta Khurana

Published in

Indian journal of medical microbiology. Pages 101293. Sep 20, 2026. Epub Sep 20, 2026.

Abstract

Primary amoebic meningoencephalitis (PAM), caused by Naegleria fowleri, is a rare but highly fatal infection of the central nervous system. Data on its epidemiology, diagnosis, and outcomes in India are limited.
To systematically review published cases of PAM in India and summarize their epidemiology, clinical characteristics, diagnostic methods, treatment, and outcomes.
We conducted a systematic search of PubMed, Web of Science, and the Cochrane Library to identify studies reporting human cases of PAM due to N. fowleri in India. Individual patient-level data on demographics, exposure history, clinical features, diagnostic methods, treatment, and outcomes were extracted. Study quality was assessed using the Joanna Briggs Institute critical appraisal tool.
Twenty-three studies reporting 24 patients from 1998 to 2025 were included. Most cases originated from Kerala (n=4), Karnataka (n=3), Uttar Pradesh (n=3), and Delhi (n=3). Freshwater exposure was documented in 15 (62.5%) patients, with environmental confirmation in two cases. Patients ranged in age from 13 days to 85 years, with a male predominance (n=20). Fever (79.2%), headache (58.3%), and seizures (41.6%) were the most common presenting features. Cerebrospinal fluid wet-mount microscopy detected trophozoites in 23 (95.8%) cases, whereas PCR confirmation was reported in only 2 cases. Amphotericin B was administered to 22 (91.6%) patients, while miltefosine was used in one case. Among evaluable patients (n=22), mortality was 63.6%.
PAM remains a rare but devastating infection with high mortality and is probably under-recognized in India. Early clinical suspicion, routine cerebrospinal fluid wet-mount examination, wider availability of molecular diagnostics, and strengthened environmental surveillance are essential for improving timely diagnosis and patient outcomes.

PMID:
42764041
Bibliographic data and abstract were imported from PubMed on 21 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.